Authors
    • Family Medicine
    • Primary Care
    • Guidelines
    • Multimorbidity
    • Prescribing Safety
    Professor of Primary Care Medicine, University of Dundee, Scotland
    Professor of Primary Care Medicine, University of Dundee, Scotland
    • Professor of Primary Care Medicine, Leader of Quality, Safety, and Informatics Research Group at University of Dundee
    Bruce Guthrie is Professor of Primary Care Medicine at the University of Dundee in Scotland where he leads the Quality, Safety and Informatics Research Group. He has held personal research fellowships from the UK Medical Research Council and National Institute of Health Research and was a Harkness Fellow in Health Policy at University of California San Francisco in 2006/7. His research focuses on multimorbidity and healthcare quality and safety, particularly in relation to prescribing with over half of all Scottish general practices participating in completed or ongoing trials of interventions to improve primary care prescribing safety. He is the Scottish Primary Care Research Champion and clinical lead for the Scottish Primary Care Research Network, and was a member of the Scottish Government working group which created the NHS Scotland guidelines on managing polypharmacy. He has regularly worked with the UK National Institute for Health and Care Excellence, including past membership of the Quality and Outcomes Framework Indicators Advisory Group which recommended the measures for the UK primary care pay for performance programme, collaboration on work to ensure that single disease guidelines better account for multimorbidity, and he is the of the Guideline Development Group for the NICE multimorbidity guideline which will publish in 2016. He works clinically as a family practitioner in a former mining town in the Fife region of Scotland.
    • Lead Pharmacist Research and Development at NHS Tayside
    Tobias Dreischulte is a post-doctoral researcher and Lead Pharmacist for Research and Development in NHS Tayside, one of 14 Scottish Health Boards serving a population of approximately 400,000 people. His research interests lie in the identification and quantification of drug safety risks (pharmacoepidemiology) and in the development and evaluation of interventions to improve the quality and safety of medication use (health services research). He has a particular interest in ambulatory care and has been selected for the prestigious Oxford International Primary Care Research Leadership Programme. In his current role, his focus is on developing and testing IT supported pharmacist-led interventions, consistent with the Scottish government's strategy to enhance the role of clinical pharmacists in ambulatory care. He is a lead author of the Scottish Polypharmacy Guidelines and an elected member of the General Committee of the European Society of Clinical Pharmacy.